Literature DB >> 11454634

Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis.

M Cutolo1, A Sulli, C Pizzorni, B Seriolo, R H Straub.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11454634      PMCID: PMC1753808          DOI: 10.1136/ard.60.8.729

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  91 in total

1.  Effects of immunomodulators on ecto-5'-nucleotidase activity on blood mononuclear cells in vitro.

Authors:  L D Christensen; V Andersen; P Nygaard; K Bendtzen
Journal:  Scand J Immunol       Date:  1992-04       Impact factor: 3.487

2.  Inhibition of the production of proinflammatory cytokines and immunoglobulins by interleukin-4 in an ex vivo model of rheumatoid synovitis.

Authors:  P Miossec; J Briolay; J Dechanet; J Wijdenes; H Martinez-Valdez; J Banchereau
Journal:  Arthritis Rheum       Date:  1992-08

Review 3.  The mechanism of action of methotrexate in rheumatoid arthritis: the search continues.

Authors:  J M Kremer
Journal:  J Rheumatol       Date:  1994-01       Impact factor: 4.666

4.  Mechanism of action of methotrexate: experimental evidence that methotrexate blocks the binding of interleukin 1 beta to the interleukin 1 receptor on target cells.

Authors:  M Brody; I Böhm; R Bauer
Journal:  Eur J Clin Chem Clin Biochem       Date:  1993-10

5.  Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes.

Authors:  F G Snijdewint; P Kaliński; E A Wierenga; J D Bos; M L Kapsenberg
Journal:  J Immunol       Date:  1993-06-15       Impact factor: 5.422

6.  Monoclonal antibody based enzyme-linked and chemiluminescent assays for the human interleukin-1 receptor antagonist. Application to measure hIL-1ra levels in monocyte cultures and synovial fluids.

Authors:  H Towbin; A Schmitz; J van Oostrum; M Seitz; B Dewald; O Zingel; J Motz; K Vosbeck; C Rordorf
Journal:  J Immunol Methods       Date:  1994-03-29       Impact factor: 2.303

7.  The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation.

Authors:  B N Cronstein; D Naime; E Ostad
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

8.  Mechanisms of methotrexate action in rheumatoid arthritis. Selective decrease in synovial collagenase gene expression.

Authors:  G S Firestein; M M Paine; D L Boyle
Journal:  Arthritis Rheum       Date:  1994-02

9.  Regulation of agonist binding to A2A adenosine receptors: effects of guanine nucleotides (GDP[S] and GTP[S]) and Mg2+ ion.

Authors:  M R Mazzoni; C Martini; A Lucacchini
Journal:  Biochim Biophys Acta       Date:  1993-12-16

10.  [Effects of methotrexate on leukotriene and derivated lipoxygenase synthesis in polynuclear neutrophils in rheumatoid polyarthritis].

Authors:  J L Leroux; M Damon; C Chavis; A Crastes De Paulet; F Blotman
Journal:  Rev Rhum Mal Osteoartic       Date:  1992-10
View more
  109 in total

1.  Methotrexate eluting stents: to modify or cure?

Authors:  A C Morton; J Gunn
Journal:  Heart       Date:  2004-02       Impact factor: 5.994

Review 2.  Anti-inflammatory therapies for atherosclerosis.

Authors:  Magnus Bäck; Göran K Hansson
Journal:  Nat Rev Cardiol       Date:  2015-02-10       Impact factor: 32.419

3.  Treatment of chronic inflammatory demyelinating polyradiculoneuropathy with methotrexate.

Authors:  D Fialho; Y-C Chan; D C Allen; M M Reilly; R A C Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04       Impact factor: 10.154

4.  Methotrexate modulates the kinetics of adenosine in humans in vivo.

Authors:  N P Riksen; P Barrera; P H H van den Broek; P L C M van Riel; P Smits; G A Rongen
Journal:  Ann Rheum Dis       Date:  2005-11-24       Impact factor: 19.103

5.  Can rheumatoid arthritis ever cease to exist: a review of various therapeutic modalities to maintain drug-free remission?

Authors:  Di Liu; Na Yuan; Guimei Yu; Ge Song; Yan Chen
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

Review 6.  Medical management of crohn disease.

Authors:  Frank I Scott; Mark T Osterman
Journal:  Clin Colon Rectal Surg       Date:  2013-06

7.  Methotrexate affects HMGB1 expression in rheumatoid arthritis, and the downregulation of HMGB1 prevents rheumatoid arthritis progression.

Authors:  Yuan-Bo Li; Peng Xu; Ke Xu; Yong-Song Cai; Meng-Yao Sun; Le Yang; Jian Sun; She-Min Lu
Journal:  Mol Cell Biochem       Date:  2016-08-13       Impact factor: 3.396

Review 8.  Understanding and controlling chronic immune activation in the HIV-infected patients suppressed on combination antiretroviral therapy.

Authors:  Babafemi Taiwo; Luis Barcena; Randall Tressler
Journal:  Curr HIV/AIDS Rep       Date:  2013-03       Impact factor: 5.071

9.  [Methotrexate in rheumatology].

Authors:  C Fiehn
Journal:  Z Rheumatol       Date:  2009-11       Impact factor: 1.372

10.  Folate metabolic pathway single nucleotide polymorphisms: a predictive pharmacogenetic marker of methotrexate response in Indian (Asian) patients with rheumatoid arthritis.

Authors:  Yogita Ghodke-Puranik; Amrutesh S Puranik; Pooja Shintre; Kalpana Joshi; Bhushan Patwardhan; Jatinder Lamba; Timothy B Niewold; Arvind Chopra
Journal:  Pharmacogenomics       Date:  2015-11-30       Impact factor: 2.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.